Newsroom: News
Artbio raises 90m USD
Artbio, which is based in Cambridge, Massachusetts, and maintains a presence in Basel (Switzerland), has raised a total of 90 million US dollars as part of an oversubscribed and upsized Series A financing round, further details of which can be found in a press release. Artbio is developing a new class of alpha radioligand therapies (ART). […]
December 13, 2023Merck pharmaceuticals (MSD) inaugurates new research lab capacities in Lucerne, Switzerland
US-based biopharma giant expands its R&D site in Schachen 2023 June 21 – Merck & Co. ($59.3B revenue), a global research-intensive biopharmaceutical company headquartered in New Jersey, has newly expanded its research laboratories in Schachen (located in Canton Lucerne) to the tune of close to 20 Million Swissfrancs. Known as Merck Sharpe & Dohme or […]
July 13, 2023IDUN receives EU funding for sleep improvement platform
Opfikon – The neurotech start-up IDUN Technologies has received Eurostars funding together with its project partners Cerebra Medical Ltd. and Pilotfish Nederland BV. This grant will be put towards the development of a personalized sleep improvement platform. The start-up IDUN Technologies from Opfikon in the canton of Zurich has received funding from the Eurostars program for its joint project […]
April 28, 2023Life Sciences CC Association founded in Ticino
Bellinzona – The Life Sciences CC Association has officially been established. It will lead the competence center for life sciences research at the future Switzerland Innovation Park Ticino. Its specific focus will be on bio-fabrication in connection with drug development. Switzerland Innovation Park Ticino has taken a major step forward in its development with the founding […]
April 28, 2023Earpiece could make post-stroke surgery a thing of the past
Zurich – Two scientists from the Swiss Federal Institute of Technology in Zurich have developed an earpiece to help speed up the recovery from a stroke. The technology stimulates the brain and could prevent the need for surgery. The solution is set to be launched on the market by a dedicated spin-off. Two researchers from […]
April 28, 2023UZH Tumor Profiler advances personalized cancer treatments
Zurich – The Tumor Profiler project of the University of Zurich (UZH) allows tumor cells to be analyzed with a degree of precision never seen before. This individual tumor profiling has already helped a third of the cancer patients in a study, causing their tumors to shrink. The University of Zurich (UZH) has announced the […]
April 28, 2023Greater Zurich Area – The Hotspot for Life Sciences in Europe’s Most Innovative Environment
In recent years, the Greater Zurich Area (GZA) has established itself as a leading center for life sciences in Europe. Major international companies are based here, attracting investors and professionals from all over the world. So, what sets Greater Zurich apart and what makes the region so attractive to companies in the healthcare industry? Switzerland […]
April 28, 2023
Lucerne University and Swiss Medtech company partner on surgical instruments
Market maturity is expected within two years’ time 2023 March 27 – Researchers from the Lucerne-based university, the Lucerne University of Applied Sciences and Arts (HSLU) are working together with the Swiss company Oertli Instrumente to develop improved instruments for cataract operations. The aim of the collaboration is to increase the efficiency of cataract operations […]
April 17, 2023
What can artificial intelligence do for health?
Algorithms help diagnose and treat diseases, discover new drugs and personalize prevention. Thus, the potential of artificial intelligence has been recognized not only by the medtech industry but also by health systems, pharmaceutical companies, patients and even the World Health Organization. What’s the state of artificial intelligence in healthcare? In 2009, Hiroshi Kobayashi, a scientist […]
January 11, 2023
CHUV, CERN and THERYQ join forces for a world first in cancer radiotherapy
CHUV, CERN and THERYQ will develop a revolutionary FLASH radiotherapy device to treat cancers resistant to conventional treatments. The Centre Hospitalier Universitaire Vaudois (CHUV), the European Laboratory for Particle Physics (CERN) and THERYQ (ALCEN Group) have signed an agreement for the world-first development of a revolutionary FLASH radiotherapy device that will use very high energy […]
January 11, 2023
Novartis investing 100 million Swiss francs in new biologics center
The pharmaceutical company Novartis is investing a sum of 100 million Swiss francs in a new competence center for biologics at its Basel campus. Here, the aim will be to accelerate the development of highly effective drugs as part of collaborative projects with scientists. The Basel-based pharmaceutical company Novartis is investing a total of 100 million […]
January 11, 2023
Artificial intelligence to improve cancer diagnosis
As part of the European BigPicture project, Henning Müller and his team from the HES-SO Valais in Sierre are developing algorithms to improve cancer diagnosis. These technologies are of interest to certain hospitals, including Sion. Since February 2021, Henning Müller, head of the eHealth Unit at the Computer Science Institute of the HES-SO Valais-Wallis in Sierre, has […]
January 11, 2023